NAAT

(redirected from Nucleic Acid Amplification Test)
AcronymDefinition
NAATNucleic Acid Amplification Test
NAATNucleic Acid Amplification Techniques
NAATNational Alliance Against Tolls (UK)
NAATNorth American Aviation Trilateral (Canada)
NAATNew Americans Against Tobacco
NAATNATO Anti-Armor Trials
References in periodicals archive ?
Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs.
Several tests are available in laboratory diagnosis of trichomoniasis, from basic microscopy to more complex rapid antigen and nucleic acid amplification tests (NAAT).
According to the agency, the Aptima Mycoplasma genitalium Assay is a nucleic acid amplification test, which detects M.
Contract Awarded for Double blinded randomized controlled Trial of Oral vancomycin versus placebo in hospitalized patients with diarrhea and stool toXin NEGative but nucleic acid amplification test positive for toxigenic Clostridium difficile (TOX NEG trial)
Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis 2005;52:247-54.
In October 2005 a more sensitive HIV nucleic acid amplification test (NAT) for blood donations was introduced in South Africa to identify donations made during the window period before seroconversion.
A nucleic acid amplification test (NAT) system for screening whole-blood donors for HIV-1 and hepatitis C virus (HCV) simultaneously The system detects these viruses at the very early stages of infection before antibodies or viral antigens appear.
The performance of a lab-developed transcription-mediated amplification (TMA) nucleic acid amplification test (NAAT) for TV and wet mount for the diagnosis of TV infections has been compared side by side in several studies.
mandatory individual nucleic acid amplification test (ID-NAT) testing of blood and tissue donors, quantitative hepatitis C (HCV) and hepatitis B (HBV) studies of blood donors and patients, as well as real-time PCR test for fetal RHD in plasma samples from pregnant.
This is the first nucleic acid amplification test to report TV results for male urine samples.
Urine specimens that have not been processed for LCx[R] resting can be tested by using another FDA-cleared nucleic acid amplification test. Only nucleic acid amplification tests are recommended for the direct detection of C.
The test is an in vitro nucleic acid amplification test for the detection and quantitation of hepatitis C virus RNA genotypes 1 to 6 in human EDTA plasma or serum.